http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-438998-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20d25237fd0ab5071fb92f675f32aaa1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 1975-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-438998-A3
titleOfInvention PROCEDURE FOR THE PREPARATION OF 7- (D-ALPHA-AMINO-PHENYLACETAMIDE) -3-DEACETOXYCEPHALOSPORANIC ACID.
abstract Process for the preparation of 7- (d-alpha-amino-phenylacetamido) -3-deacetoxycephalosporanic acid of formula ** (see formula) ** Where n is 0, 1, 2 or 3, characterized because: in a first phase, A) the 7-aminodesacetoxycephalosporanic acid of formula iid is reacted with trimethylchlorosilane or dimethylchlorosilane or with chloromethyl pivalate in methylene chloride or chloroform, in the presence of amine compounds of the triethylamine and dimethylaniline type, diethylaniline, quinoline, isoquinoline or pyridine, at a temperature higher than 20ºC but lower than 60º c; in a second phase, B) the silylated derivative or the pivaloyloxymethyl ester of 7-aminodesacetoxycephalosporanic acid, resulting from the previous step, is reacted with d-phenylglycine chloride hydrochloride, likewise in the presence of dimethylaniline, diethylaniline, quinoline, isoquinoline or pyridine; in a third phase, C) the sealed derivative or the pivaloyloxymethyl ester of cefalexin, formed in the previous phase, is hydrolyzed by the addition of water at a ph of 1.0 to 1.5; D) by following the phases in which the raw cephalexin is isolated directly by the addition of ammonia or triethylamine to a ph of 3.5 to 4.5 and E) in which the cefalexina is purified by suspending it in water at a temperature of 50 to 70º c. (Machine-translation by Google Translate, not legally binding)
priorityDate 1975-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86738798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410509619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449216609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412216270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424983022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407559142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 42.